333 related articles for article (PubMed ID: 37310269)
21. Emergence of non-Candida albicans species: Epidemiology, phylogeny and fluconazole susceptibility profile.
Sadeghi G; Ebrahimi-Rad M; Mousavi SF; Shams-Ghahfarokhi M; Razzaghi-Abyaneh M
J Mycol Med; 2018 Mar; 28(1):51-58. PubMed ID: 29366545
[TBL] [Abstract][Full Text] [Related]
22. Study of Candidemia and its Antifungal Susceptibility Profile at the University Hospital of Montevideo, Uruguay.
Carbia M; Medina V; Bustillo C; Martínez C; González MP; Ballesté R
Mycopathologia; 2023 Dec; 188(6):919-928. PubMed ID: 37314581
[TBL] [Abstract][Full Text] [Related]
23. Alarming Increase of Azole-Resistant Candida Causing Blood Stream Infections in Oncology Patients in Egypt.
El-Mahallawy HA; Abdelfattah NE; Wassef MA; Abdel-Hamid RM
Curr Microbiol; 2023 Oct; 80(11):362. PubMed ID: 37796322
[TBL] [Abstract][Full Text] [Related]
24. Epidemiological Trends of Fungemia in Greece with a Focus on Candidemia during the Recent Financial Crisis: a 10-Year Survey in a Tertiary Care Academic Hospital and Review of Literature.
Siopi M; Tarpatzi A; Kalogeropoulou E; Damianidou S; Vasilakopoulou A; Vourli S; Pournaras S; Meletiadis J
Antimicrob Agents Chemother; 2020 Feb; 64(3):. PubMed ID: 31871083
[TBL] [Abstract][Full Text] [Related]
25. Epidemiology and antifungal susceptibility patterns of candidemia from a tertiary centre in Western Australia.
Boan P; Gardam D
J Chemother; 2019 May; 31(3):137-140. PubMed ID: 30955472
[TBL] [Abstract][Full Text] [Related]
26. Clinical manifestations of candidemia caused by uncommon Candida species and antifungal susceptibility of the isolates in a regional hospital in Taiwan, 2007-2014.
Liu WL; Lai CC; Li MC; Wu CJ; Ko WC; Hung YL; Tang HJ; Hsueh PR
J Microbiol Immunol Infect; 2019 Aug; 52(4):612-619. PubMed ID: 28886952
[TBL] [Abstract][Full Text] [Related]
27. Epidemiology, species distribution, antifungal susceptibility and mortality risk factors of candidemia among critically ill patients: a retrospective study from 2011 to 2017 in a teaching hospital in China.
Xiao Z; Wang Q; Zhu F; An Y
Antimicrob Resist Infect Control; 2019; 8():89. PubMed ID: 31161036
[TBL] [Abstract][Full Text] [Related]
28. Species distribution and antifungal drug susceptibilities of yeasts isolated from the blood samples of patients with candidemia.
Lindberg E; Hammarström H; Ataollahy N; Kondori N
Sci Rep; 2019 Mar; 9(1):3838. PubMed ID: 30846717
[TBL] [Abstract][Full Text] [Related]
29. Analysis of global antifungal surveillance results reveals predominance of Erg11 Y132F alteration among azole-resistant Candida parapsilosis and Candida tropicalis and country-specific isolate dissemination.
Castanheira M; Deshpande LM; Messer SA; Rhomberg PR; Pfaller MA
Int J Antimicrob Agents; 2020 Jan; 55(1):105799. PubMed ID: 31520783
[TBL] [Abstract][Full Text] [Related]
30. Surveillance Study of Epidemiology, Antifungal Susceptibility and Risk Factors of Invasive Candidiasis in Critically ill Patients.
Wang B; Wang Y; Zhang L; Lu F; Zhang M; Xu Y
Clin Lab; 2022 Jun; 68(6):. PubMed ID: 35704741
[TBL] [Abstract][Full Text] [Related]
31. Epidemiology of bloodstream Candida species in a Spanish tertiary care hospital as a guide for implementation of T2MR (T2CANDIDA®) for rapid diagnosis of candidemia.
Falces-Romero I; Romero-Gómez MP; Moreno-Ramos F; Mingorance J; García-Rodríguez J; Cendejas-Bueno E
Med Mycol; 2021 Apr; 59(4):350-354. PubMed ID: 32634233
[TBL] [Abstract][Full Text] [Related]
32. Epidemiology, risk factor, species distribution, antifungal resistance and outcome of Candidemia at a single French hospital: a 7-year study.
Tadec L; Talarmin JP; Gastinne T; Bretonnière C; Miegeville M; Le Pape P; Morio F
Mycoses; 2016 May; 59(5):296-303. PubMed ID: 26806101
[TBL] [Abstract][Full Text] [Related]
33. Surveillance study of species distribution, antifungal susceptibility and mortality of nosocomial candidemia in a tertiary care hospital in China.
Ma CF; Li FQ; Shi LN; Hu YA; Wang Y; Huang M; Kong QQ
BMC Infect Dis; 2013 Jul; 13():337. PubMed ID: 23875950
[TBL] [Abstract][Full Text] [Related]
34. A seven-year surveillance study of the epidemiology, antifungal susceptibility, risk factors and mortality of candidaemia among paediatric and adult inpatients in a tertiary teaching hospital in China.
Zeng Z; Ding Y; Tian G; Yang K; Deng J; Li G; Liu J
Antimicrob Resist Infect Control; 2020 Aug; 9(1):133. PubMed ID: 32799915
[TBL] [Abstract][Full Text] [Related]
35. Epidemiology and antifungal susceptibility of candidemia isolates of non-albicans Candida species from cancer patients.
Wu PF; Liu WL; Hsieh MH; Hii IM; Lee YL; Lin YT; Ho MW; Liu CE; Chen YH; Wang FD
Emerg Microbes Infect; 2017 Oct; 6(10):e87. PubMed ID: 29018251
[TBL] [Abstract][Full Text] [Related]
36. The changing face of candidemia: emergence of non-Candida albicans species and antifungal resistance.
Nguyen MH; Peacock JE; Morris AJ; Tanner DC; Nguyen ML; Snydman DR; Wagener MM; Rinaldi MG; Yu VL
Am J Med; 1996 Jun; 100(6):617-23. PubMed ID: 8678081
[TBL] [Abstract][Full Text] [Related]
37. Candida orthopsilosis fungemias in a Spanish tertiary care hospital: incidence, epidemiology and antifungal susceptibility.
Blanco-Blanco MT; Gómez-García AC; Hurtado C; Galán-Ladero MA; Lozano Mdel C; García-Tapias A; Blanco MT
Rev Iberoam Micol; 2014; 31(2):145-8. PubMed ID: 23680638
[TBL] [Abstract][Full Text] [Related]
38. Distribution and drug susceptibilities of Candida species causing candidemia from a medical center in central Taiwan.
Chang TP; Ho MW; Yang YL; Lo PC; Lin PS; Wang AH; Lo HJ
J Infect Chemother; 2013 Dec; 19(6):1065-71. PubMed ID: 23732308
[TBL] [Abstract][Full Text] [Related]
39. Antifungal susceptibility of invasive Candida bloodstream isolates from the Asia-Pacific region.
Tan TY; Hsu LY; Alejandria MM; Chaiwarith R; Chinniah T; Chayakulkeeree M; Choudhury S; Chen YH; Shin JH; Kiratisin P; Mendoza M; Prabhu K; Supparatpinyo K; Tan AL; Phan XT; Tran TT; Nguyen GB; Doan MP; Huynh VA; Nguyen SM; Tran TB; Van Pham H
Med Mycol; 2016 Jul; 54(5):471-7. PubMed ID: 26868904
[TBL] [Abstract][Full Text] [Related]
40. In Vitro Antifungal Activity of Azoles and Other Antifungal Agents Against Pathogenic Yeasts from Vulvovaginal Candidiasis in China.
Kan S; Song N; Pang Q; Mei H; Zheng H; Li D; Cui F; Lv G; An R; Li P; Xiong Z; Fan S; Zhang M; Chen Y; Qiao Q; Liang X; Cui M; Li D; Liao Q; Li X; Liu W
Mycopathologia; 2023 Apr; 188(1-2):99-109. PubMed ID: 36378354
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
